ViroLogic announces agreement with Achillion.
D017322:Clinical Trials, Phase II as Topic; D003299:Cooperative Behavior; D004345:Drug Industry / Q000639:trends*; D024882:Drug Resistance, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D006509:Hepatitis B / Q000188:drug therapy; D006801:Humans; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000494:pharmacology
D016047:Zalcitabine; C099405:dexelvucitabine